News Releases

Biogen to Present at the Morgan Stanley 17th Annual Global Healthcare Conference

August 27, 2019 at 4:05 PM EDT

Cambridge, MA, - - Biogen Inc.  (Nasdaq: BIIB) announced today that it will present at the Morgan Stanley 17th Annual Global Healthcare Conference. The webcast will be live on Monday, September 9, at 9:55 a.m. ET. To access the live webcast, please visit Biogen’s Investors section at www.biogen.com/investors.  An archived version of the webcast will be available following the presentation.

 

About Biogen
At Biogen, our mission is clear: we are pioneers in neuroscience. Biogen discovers, develops, and delivers worldwide innovative therapies for people living with serious neurological and neurodegenerative diseases as well as related therapeutic adjacencies. One of the world’s first global biotechnology companies, Biogen was founded in 1978 by Charles Weissmann, Heinz Schaller, Kenneth Murray, and Nobel Prize winners Walter Gilbert and Phillip Sharp, and today has the leading portfolio of medicines to treat multiple sclerosis, has introduced the first approved treatment for spinal muscular atrophy, commercializes biosimilars of advanced biologics and is focused on advancing neuroscience research programs in multiple sclerosis and neuroimmunology, neuromuscular disorders, movement disorders, Alzheimer’s disease and dementia, ophthalmology, immunology, neurocognitive disorders, acute neurology and pain.

 

We routinely post information that may be important to investors on our website at www.biogen.com. To learn more, please visit www.biogen.com and follow us on social media – Twitter, LinkedIn, Facebook, YouTube.

 

Contact:

Karen Jewell

Investor Relations

Biogen

781-464-2442